Pharma

Your Article Summary

See Latest Articles

Study Shows Superior Efficacy for TAXUS Express Stents Compared to Bare-Metal Stents in Heart Attack Patients at Two Years
Boston Scientific, 09/28/09

Boston Scientific Corporation announced two–year follow–up data from the HORIZONS–AMI trial. The trial, sponsored by the Cardiovascular Research Foundation with grant support from Boston Scientific and The Medicines Company, is designed to determine the safety and efficacy of the TAXUS Express2™ Paclitaxel–Eluting Coronary Stent System compared to bare–metal stenting in patients experiencing an acute myocardial infarction, or heart attack.

Today in Drug Trials...keeping you current

Receive free subspecialty "5-minute updates" via email

Repligen Reports Phase 3 Clinical Trial Results of RG1068 in Pancreatic Imaging
Repligen, 12/10/09

Phase I Study of Intravenous Vascular Endothelial Growth Factor Trap, Aflibercept, in Patients With Advanced Solid Tumors
Journal of Clinical Oncology, 12/10/09

Fyi from human genome sciences: gsk initiates second pivotal phase 3 trial for investigational cardiovascular medication darapladib
Human Genome Sciences, 12/10/09

 See all of Drug Trials